Phibro Animal Health Corporation cash flow to debt ratio of 8.74% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Phibro Animal Health Corporation's free cash flow has decreased 76.41% from $41.83M last year to $9.87M, signaling decreasing performance

Phibro Animal Health Corporation's debt to equity ratio is 2.05, which means that the company's assets are unhealthy financed, signaling financial risk.

Phibro Animal Health Corporation's debt has decreased relative to shareholder equity from 2.67 last year to 2.05 today, signaling strengthened financials

Phibro Animal Health Corporation has a net debt to EBITDA ratio of 2.99x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Phibro Animal Health Corporation's interest coverage ratio of 4.17 indicates that earnings with good margin can cover interest payments on company debt

Phibro Animal Health Corporation's profit margin was 3.72% last year and is 6.57% this year, signaling increasing performance

Phibro Animal Health Corporation's short-term assets of $935.51M exceed its short-term liabilities of $316.47M

Phibro Animal Health Corporation's return on assets of 6.64% is higher than the 5.00% threshold, indicating efficient asset utilization

Phibro Animal Health Corporation's return on equity of 28.67%, is higher than 15.00%, indicating good performance

Phibro Animal Health Corporation's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Phibro Animal Health Corporation had positive net income in 5 out of 5 years, indicating stable and consistent earnings

Phibro Animal Health Corporation has positive free cash flow, indicating the company generates cash after capital expenditures

Phibro Animal Health Corporation has a free cash flow yield of 0.69%, which is below the 2.00% threshold, indicating limited cash return relative to market value

Phibro Animal Health Corporation's yearly earnings has increased 106.61% since last year from $48.26M to $99.72M, signaling increasing performance

Phibro Animal Health Corporation's yearly revenue has increased 17.12% since last year from $1.30B to $1.52B, signaling increasing performance

ROIC 11.81% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Phibro Animal Health Corporation's 3-year revenue CAGR of 15.79% is positive, indicating growing revenue over the past 3 years

Phibro Animal Health Corporation had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Phibro Animal Health Corporation had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

Phibro Animal Health Corporation has insufficient data to evaluate this check.

Phibro Animal Health Corporation has an earnings yield of 6.93%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Phibro Animal Health Corporation is overvalued relative to its fair value price of 23.14 based on Base EBITDA Valuation model

Phibro Animal Health Corporation has an EV/EBITDA ratio of 9.07x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Phibro Animal Health Corporation is undervalued relative to its fair value price of 61.62 based on Base Earnings Fair Value model

Phibro Animal Health Corporation has a PEG-ratio over 1 which is considered overvalued

Phibro Animal Health Corporation has a price-to-book ratio of 3.73x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Phibro Animal Health Corporation has a price-to-sales ratio of 0.95x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue